| Financial Year |
March 31 2023 |
| Monetary Funds |
677,755,364.60 |
| Held-for-trading Financial Assets |
69,536,685.18 |
| Notes Receivable |
39,942,543.90 |
| Accounts Receivable |
1,029,221,092.31 |
| Advances to Suppliers |
40,120,817.21 |
| Other Receivables |
66,089,504.18 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
2,132,435.14 |
| Inventories |
685,775,119.72 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
323,578.02 |
| Other Current Assets |
16,544,232.24 |
| Total Current Assets |
2,772,234,668.55 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
2,136,370.61 |
| Long-term Equity Investment |
233,519,210.23 |
| Investment Properties |
-- |
| Fixed Assetes |
293,852,709.01 |
| Under-construction Projects |
41,229,347.05 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
147,213,667.97 |
| R&D expenses |
17,639,684.00 |
| Goodwill |
5,738,367.20 |
| Long-Term Deferred and Prepaid Expenses |
3,313,131.39 |
| Deferred Income Tax Assets |
84,282,756.42 |
| Other Non-Current Assets |
1,643,768.00 |
| Sub-Total of Non-Current Assets |
835,980,549.51 |
| Total Assets |
3,608,215,218.06 |
| Short-Term Loans |
207,796,181.26 |
| Trading Financial liabilities |
-- |
| Notes Payable |
151,795,111.87 |
| Accounts Payable |
636,451,342.42 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
39,246,273.81 |
| Taxes Payable |
6,029,135.94 |
| Interest Payable |
-- |
| Dividend Payable |
1,149,500.00 |
| Other payables |
11,996,822.25 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
323,523,516.08 |
| Other Current Liabilities |
47,064,530.03 |
| Sub-Total of Current Liabilities |
1,502,129,102.92 |
| Long-term Loans |
66,100,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
112,675,722.17 |
| Total Liabilities |
1,614,804,825.09 |
| Paid-In Capital(Or Share Stock) |
504,092,274.00 |
| Capital Surplus |
448,670,016.69 |
| Surplus Reserve |
89,780,944.85 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
641,001,940.56 |
| Minority Stockholder's Interest |
309,865,216.87 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,683,545,176.10 |
| Owner's Equity（Stockholder's Equity） |
1,993,410,392.97 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,608,215,218.06 |
